Search

Search Results
Results 491 - 500 of 800 for Male breast cancer
  • News - 23 Feb 2026
    After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more...
  • Drug - 23 Jan 2026
    Consumer Medicine Information (CMI) about Dutasteride/tamsulosin Viatris 500/400 intended for persons living in Australia.
  • News - 19 Jan 2026
    A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to hereditary cancer and familial hypercholesterolaemia, identifying clinically...
  • Drug - 19 Jan 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.
  • Drug - 9 Jan 2026
    Consumer Medicine Information (CMI) about Finasteride Viatris 5 intended for persons living in Australia.
  • News - 16 Dec 2025
    Pathology has long been the cornerstone of cancer diagnosis and treatment. A pathologist carefully examines an ultrathin slice of human tissue under a microscope for clues that indicate the presence,...
  • Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Diphereline intended for persons living in Australia.
  • Drug - 10 Nov 2025
    Consumer Medicine Information (CMI) about DBL Vincristine Sulfate Injection intended for persons living in Australia.
  • Drug - 20 Oct 2025
    Consumer Medicine Information (CMI) about Itovebi intended for persons living in Australia.
  • Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.